MedCity News June 21, 2022
Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.
Human Longevity, Inc., (HLI), a company aiming to use genomic insights to help people live longer, has found a way to extend its corporate life. The firm has reached a merger deal that will take the company public and infuse it with $345 million to bring its life-extending approach to more users in the U.S. and around the world.
San Diego-based...
Today's Sponsors
Today's Sponsor